RxDoctor Payments Data

Warren Zuckerman

Pediatric Cardiology · New York, NYNPI 1245483551

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $742 of the $1,152 with a category attached, or 64.4%. Merck accounts for 80.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $932 and has fallen 92.5% since, to $70 in 2025.

$1,152in general payments, 2019–2025

Across 15 payments — averaging $76.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$932
  • One Lambda, Inc.$113
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$47
  • Abbott$44
  • Takeda Pharmaceuticals U.S.A., Inc.$17
$491,754in research payments, 2019–2025

Across 24 payments — averaging $20,490 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$359K
  • Merck$132K

What the payments were for

  • Travel & lodging$74264%
  • Food & beverage$40936%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,152 in reported general payments places this provider in the 70th percentile of 147 pediatric cardiology providers in New York.

See all pediatric cardiology providers in New York

Other pediatric cardiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →